Medplus Health Services Ltd

Medplus Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medplus Health Services Ltd

₹ 855 1.21%
13 Dec - close price
medplusindia.com BSE: 543427 NSE: MEDPLUS
About
Key Points

India's Leading Pharmacy Company[1][2]
MedPlus is the 2nd largest pharmacy retailer in India, with 4,552 stores across 12 states and 1 union territory as of Q2 FY25. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

  • Store Distribution by Region[1]
  • Telangana: 679 stores
  • Andhra Pradesh: 454 stores
  • Karnataka: 893 stores
  • Tamil Nadu: 845 stores
  • West Bengal: 506 stores
  • Maharashtra: 553 stores
  • Odisha: 149 stores
  • Chhattisgarh: 4 stores
  • Madhya Pradesh: 4 stores
  • Puducherry: 5 stores
  • Delhi: 1 store

The stores increased with 108 net new stores added in Q2 FY2025, of which 71 were in Tier-2 and Tier-3 cities[3]

Website BSE NSE
  • Market Cap ₹ 10,221 Cr.
  • Current Price ₹ 855
  • High / Low ₹ 877 / 598
  • Stock P/E 102
  • Book Value ₹ 137
  • Dividend Yield 0.00 %
  • ROCE 6.66 %
  • ROE 4.10 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company's working capital requirements have reduced from 84.8 days to 67.6 days

Cons

  • Stock is trading at 6.25 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 4.98% over last 3 years.
  • Promoters have pledged 54.2% of their holding.
  • Promoter holding has decreased over last 3 years: -56.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Retail Industry: Trading

Part of Nifty Microcap 250 BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty Total Market BSE 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
925 933 966 994 1,121 1,190 1,253 1,284 1,409 1,441 1,490 1,489 1,576
863 872 914 941 1,061 1,119 1,171 1,213 1,324 1,350 1,385 1,395 1,452
Operating Profit 62 61 52 53 60 72 82 71 85 92 106 94 124
OPM % 7% 7% 5% 5% 5% 6% 7% 6% 6% 6% 7% 6% 8%
7 7 13 10 11 11 14 9 10 10 10 9 12
Interest 16 17 19 20 20 21 22 23 24 24 25 25 25
Depreciation 28 30 34 38 42 46 56 52 55 57 59 60 63
Profit before tax 25 22 13 5 9 16 17 5 16 20 32 18 48
Tax % 20% 22% 10% 24% 27% 17% -54% 26% 12% 31% -5% 19% 19%
20 17 11 4 6 13 27 4 15 14 34 14 39
EPS in Rs 6.31 1.44 0.98 0.27 0.55 1.12 2.23 0.32 1.22 1.15 2.79 1.20 3.24
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,368 1,733 2,011 2,131 2,273 2,871 3,069 3,779 4,558 5,625 5,997
1,336 1,696 1,940 2,073 2,153 2,737 2,852 3,507 4,292 5,270 5,581
Operating Profit 32 37 71 58 120 134 217 273 266 355 416
OPM % 2% 2% 4% 3% 5% 5% 7% 7% 6% 6% 7%
4 8 7 8 11 17 21 31 46 40 41
Interest 14 17 19 28 50 47 55 66 83 96 99
Depreciation 9 10 11 12 59 75 88 119 182 224 240
Profit before tax 14 19 48 26 23 29 95 118 47 73 118
Tax % 46% 52% 40% -65% 48% 94% 34% 20% -6% 11%
7 9 29 42 12 2 63 95 50 66 100
EPS in Rs 419.34 508.71 1,620.57 2,080.06 585.46 107.02 1,393.11 8.03 4.17 5.48 8.38
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 22%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 38%
3 Years: 1%
TTM: 72%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 14%
Return on Equity
10 Years: %
5 Years: 5%
3 Years: 5%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.17 0.17 0.17 0.19 0.19 0.19 0.45 24 24 24 24
Reserves 141 137 148 303 291 528 730 1,394 1,467 1,554 1,612
170 223 204 162 429 477 590 815 900 1,010 1,030
126 149 183 179 239 344 245 361 406 417 489
Total Liabilities 438 509 535 644 959 1,349 1,566 2,594 2,797 3,005 3,155
67 77 81 83 377 419 517 799 1,138 1,242 1,231
CWIP 3 3 2 1 1 5 6 20 25 11 11
Investments 0 0 0 0 0 0 0 0 0 0 0
368 429 453 560 580 924 1,043 1,775 1,633 1,752 1,913
Total Assets 438 509 535 644 959 1,349 1,566 2,594 2,797 3,005 3,155

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-19 -17 34 32 147 -7 3 170 90 144
-16 -32 -15 -18 -19 -28 -35 -703 429 -83
67 35 -29 -1 -83 90 -6 440 -170 -198
Net Cash Flow 32 -15 -10 14 45 56 -37 -93 350 -137

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 1 1 0 2 1 1 1 1 1 1
Inventory Days 84 82 76 76 78 101 113 112 117 111
Days Payable 34 29 25 27 31 37 22 30 27 21
Cash Conversion Cycle 51 53 51 51 48 65 91 82 91 92
Working Capital Days 42 41 39 39 31 45 69 121 66 68
ROCE % 11% 19% 13% 12% 9% 13% 10% 5% 7%

Shareholding Pattern

Numbers in percentages

16 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
40.43% 40.43% 40.43% 40.43% 40.43% 40.43% 40.43% 40.41% 40.45% 40.39% 40.39% 40.39%
3.42% 2.97% 3.15% 3.74% 3.94% 4.48% 4.87% 12.36% 12.96% 14.94% 14.85% 14.72%
27.72% 29.24% 29.48% 28.84% 28.77% 28.16% 28.13% 25.50% 25.19% 22.47% 22.17% 27.98%
28.08% 27.01% 26.58% 26.64% 26.56% 26.73% 26.42% 21.61% 21.31% 22.10% 22.51% 16.85%
0.35% 0.35% 0.35% 0.35% 0.29% 0.19% 0.15% 0.12% 0.10% 0.10% 0.08% 0.07%
No. of Shareholders 1,02,77982,62777,11976,97274,70273,51270,01766,43066,04874,97676,93487,328

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls